HomeGeneticsConditionRigid spine muscular dystrophy
Back to Condition
Rigid spine muscular dystrophy
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Rigid spine muscular dystrophy

Rigid spine muscular dystrophy (RSMD) is a form of congenital muscular dystrophy characterized by early-onset muscle weakness, spine stiffness, and serious respiratory complications.

Overview

Rigid spine muscular dystrophy (RSMD) is a form of congenital muscular dystrophy. Disorders in this group cause muscle weakness and wasting (atrophy) beginning very early in life. In particular, RSMD involves weakness of the muscles of the torso and neck (axial muscles). Other characteristic features include spine stiffness and serious breathing problems.

In RSMD, muscle weakness is often apparent at birth or within the first few months of life. Affected infants can have poor head control and weak muscle tone (hypotonia), which may delay the development of motor skills such as crawling or walking. Over time, muscles surrounding the spine atrophy, and the joints of the spine develop deformities called contractures that restrict movement. The neck and back become stiff and rigid, and affected children have limited ability to move their heads up and down or side to side. Affected children eventually develop an abnormal curvature of the spine. In some people with RSMD, muscles in the inner thighs also atrophy, although it does not impair the ability to walk.

A characteristic feature of RSMD is breathing difficulty (respiratory insufficiency) due to restricted movement of the torso and weakness of the diaphragm, which is the muscle that separates the abdomen from the chest cavity. The breathing problems, which tend to occur only at night, can be life-threatening. Many affected individuals require a machine to help them breathe (mechanical ventilation) during sleep.

Frequency

RSMD is thought to be a rare disorder, although its prevalence is unknown.

Causes

Mutations in a gene called SELENON (formerly SEPN1) cause about 40 percent of cases of RSMD. When caused by mutations in this gene, the condition is known as rigid spine muscular dystrophy 1 (RSMD1). The genetic cause of the remainder of cases is unknown.

The SELENON gene provides instructions for making a protein known as selenoprotein N. While its specific job is unknown, researchers suspect it plays a role in the formation of muscle tissue before birth and is important for normal muscle function after birth. The gene mutations that cause RSMD1 are thought to reduce the amount of selenoprotein N or impair its activity in cells.

Gene Associated with Rigid Spine Muscular Dystrophy

  • SELENON

Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Other Names for This Condition

  • Congenital muscular dystrophy with spine rigidity syndrome
  • Muscular dystrophy, congenital, merosin-positive, with early spine rigidity
  • Rigid spinal muscular dystrophy
  • Rigid spine congenital muscular dystrophy
  • RSMD

Frequently Asked Questions

Yes. Targeted panel testing or whole‑exome sequencing can identify pathogenic variants in genes such as SEPN1, LMNA, and COL6A1‑3, which are linked to RSMD phenotypes. A confirmed molecular diagnosis guides counseling, informs prognosis, and may qualify the patient for clinical trials.
multidisciplinary approach is key: daily gentle stretching of the cervical and lumbar paraspinals, supervised physiotherapy focusing on active range‑of‑motion exercises, and use of custom‑fitted orthoses (e.g., thoracolumbosacral braces) to support the spine while allowing movement. Regular reassessment by a physiatrist helps adjust the program as contractures progress.
Look for poor head control, generalized hypotonia, difficulty lifting the head, delayed motor milestones (e.g., late crawling or walking), and early stiffness of the neck or back. If axial weakness is evident within the first few months, referral for neuromuscular evaluation and genetic testing is warranted.
Pulmonary function tests (spirometry, forced vital capacity) and overnight oximetry or polysomnography are used to assess breathing. A drop in oxygen saturation below 90 % for more than a few minutes, hypercapnia, or symptoms such as morning headaches and daytime fatigue signal the need for non‑invasive ventilation (e.g., BiPAP) during sleep. Early initiation can prevent life‑threatening hypoventilation.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA